Trigeminal autonomic cephalalgias

CONTINUUM Lifelong Learning in Neurology

Volumn 18, Issue 4, 2012, Pages 883-895

  Goadsby, Peter J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; HYDROCODONE BITARTRATE PLUS PARACETAMOL; INDOMETACIN; LAMOTRIGINE; LITHIUM; MELATONIN; METHYSERGIDE; THYROXINE; TOPIRAMATE; TRIPTAN DERIVATIVE; VERAPAMIL;

CLINICAL FEATURE; CLUSTER HEADACHE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; HEADACHE; HEMICRANIA CONTINUA; HUMAN; HYPOPHYSIS; NAUSEA; PAROXYSMAL HEMICRANIA; PHONOPHOBIA; PHOTOPHOBIA; REVIEW; SINUS HEADACHE; SUNCT SYNDROME; TREATMENT RESPONSE; TRIGEMINAL AUTONOMIC CEPHALALGIA;

AUTONOMIC NERVOUS SYSTEM; DIAGNOSIS, DIFFERENTIAL; FUNCTIONAL LATERALITY; HUMANS; MALE; MIDDLE AGED; TRIGEMINAL AUTONOMIC CEPHALALGIAS;

EID: 84864871938     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000418649.54902.0b     Document Type: Review

References (45)

1. Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain 1997;120(1) 193-209. (Pubitemid 27081270)
2. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders. 2nd edition. Cephalalgia 2004;24(suppl 1) 9-160.
3. Goadsby PJ, Cittadini E, Burns B, Cohen AS. Trigeminal autonomic cephalalgias diagnostic and therapeutic developments. Curr Opin Neurol 2008;21(3) 323-330. (Pubitemid 351653983)
4. Frese A, Evers S, May A. Autonomic activation in experimental trigeminal pain. Cephalalgia 2003;23(1) 67-68. (Pubitemid 36356808)
5. Obermann M, Yoon M-S, Dommes P, et al. Prevalence of trigeminal autonomic symptoms in migraine a population-based study. Cephalalgia 2007;27(6) 504-509. (Pubitemid 46848914)
6. Eross E, Dodick D, Eross M. The Sinus, Allergy and Migraine Study (SAMS). Headache 2007;47(2) 213-224.
7. Schreiber CP, Hutchinson S, Webster CJ, et al. Prevalence of migraine in patients with a history of self-reported or physician-diagnosed sinus headache. Arch Intern Med 2004;164(16) 1769-1772. (Pubitemid 39215646)
8. Schreiber CP, Cady RK, Billings C. Oral sumatriptan for self-described sinus headache. Cephalalgia 2001;21 291.
9. Bahra A, Goadsby PJ. Diagnostic delays and mis-management in cluster headache. Acta Neurol Scand 2004;109(3) 175-179. (Pubitemid 38270871)
10. May A, Goadsby PJ. The trigeminovascular system in humans pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab 1999;19(2) 115-127. (Pubitemid 29284258)
11. Irimia P, Cittadini E, Paemeleire K, et al. Unilateral photophobia or phonophobia in migraine compared with trigeminal autonomic cephalalgias. Cephalalgia 2008;28(6) 626-630. (Pubitemid 351614935)
12. Lai T-H, Fuh J-L, Wang S-J. Cranial autonomic symptoms in migraine characteristics and comparison with cluster headache. J Neurol Neurosurg Psychiatry 2009;80(10) 1116-1119.
13. Levy M, Matharu MS, Meeran K, et al. The clinical characteristics of headache in patients with pituitary tumours. Brain 2005;128(pt 8) 1921-1930. (Pubitemid 41373664)
14. Sprenger T, Goadsby PJ. What has functional neuroimaging done for primary headacheIand for the clinical neurologist? J Clin Neurosci 2010;17(5) 547-553.
15. Favier I, van Vliet JA, Roon KI, et al. Trigeminal autonomic cephalgias due to structural lesions a review of 31 cases. Arch Neurol 2007;64(1) 25-31. (Pubitemid 46072420)
16. Olesen J, Tfelt-Hansen P, Ramadan N, et al. The Headaches. Philadelphia, PA Lippincott Williams & Wilkins, 2005.
17. May A, Bahra A, Buchel C, et al. Hypothalamic activation in cluster headache attacks. Lancet 1998;352(9124) 275-278. (Pubitemid 28340145)
18. May A, Ashburner J, Buchel C, et al. Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med 1999;5(7) 836-838. (Pubitemid 29318621)
19. May A, Leone M, Afra J, et al. EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol 2006;13(10) 1066-1077. (Pubitemid 44434311)
20. Bussone G, Leone M, Peccarisi C, et al. Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache 1990;30(7) 411-417. (Pubitemid 20376073)
21. Cohen AS, Matharu MS, Goadsby PJ. Electrocardiographic abnormalities in patients with cluster headache on verapamil therapy. Neurology 2007;69(7) 668-675. (Pubitemid 47256009)
22. Cohen AS, Burns B, Goadsby PJ. High-flow oxygen for treatment of cluster headache a randomized trial. JAMA 2009;302(22) 2451-2457.
23. Treatment of acute cluster headache with sumatriptan. The Sumatriptan Cluster Headache Study Group. N Engl J Med 1991;325(5) 322-326.
24. van Vliet JA, Bahra A, Martin V, et al. Intranasal sumatriptan in cluster headache randomized placebo-controlled double-blind study. Neurology 2003;60(4) 630-633. (Pubitemid 36246081)
25. Cittadini E, May A, Straube A, et al. Effectiveness of intranasal zolmitriptan in acute cluster headache a randomized, placebo-controlled, double-blind crossover study. Arch Neurol 2006;63(11) 1537-1542. (Pubitemid 44748795)
26. Leone M, Proietti Cecchini A, Franzini A, et al. Lessons from 8 years' experience of hypothalamic stimulation in cluster headache. Cephalalgia 2008;28(7) 787-797.
27. Burns B, Watkins L, Goadsby PJ. Successful treatment of medically intractable cluster headache using occipital nerve stimulation (ONS). Lancet 2007;369 1099-1106. (Pubitemid 46483638)
28. Cittadini E, Matharu MS, Goadsby PJ. Paroxysmal hemicrania a prospective clinical study of 31 cases. Brain 2008;131(pt 4) 1142-1155. (Pubitemid 351499421)
29. Cohen AS, Matharu MS, Goadsby PJ. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA)-a prospective clinical study of SUNCT and SUNA. Brain 2006;129(pt 10) 2746-2760. (Pubitemid 44522107)
30. Bahra A, May A, Goadsby PJ. Cluster headache a prospective clinical study with diagnostic implications. Neurology 2002;58(3) 354-361. (Pubitemid 34150907)
31. Sjaastad O. Chronic paroxysmal hemicrania, hemicrania continua and SUNCT the fate of the three first described cases. J Headache Pain 2006;7(3) 151-156. (Pubitemid 44419850)
32. Cohen AS, Goadsby PJ. Paroxysmal hemicrania responding to topiramate. J Neurol Neurosurg Psychiatry 2007;78(1) 96-97. (Pubitemid 46048274)
33. Afridi SK, Shields KG, Bhola R, Goadsby PJ. Greater occipital nerve injection in primary headache syndromes-prolonged effects from a single injection. Pain 2006;122(1-2) 126-129.
34. Cohen AS, Matharu MS, Goadsby PJ. Suggested guidelines for treating SUNCT and SUNA. Cephalalgia 2005;25 1200.
35. Cohen A, Matharu MS, Goadsby PJ. Double-blind placebo-controlled trial of topiramate in SUNCT. Cephalalgia 2007;27 758.
36. Matharu MS, Cohen AS, Goadsby PJ. Intravenous lidocaine is effective in the treatment of SUNCT syndrome. Cephalalgia 2003;23 738.
37. Cittadini E, Goadsby PJ. Hemicrania continua a clinical study of 39 patients with diagnostic implications. Brain 2010;133(pt 7) 1973-1986.
38. Medina JL, Diamond S. Cluster headache variant. Spectrum of a new headache syndrome. Arch Neurol 1981;38(11) 705-709. (Pubitemid 11029561)
39. Sjaastad O, Spierings EL. Hemicrania continua another headache absolutely responsive to indomethacin. Cephalalgia 1984;4(1) 65-70. (Pubitemid 14133042)
40. Newman LC, Lipton RB, Solomon S. Hemicrania continua ten new cases and a review of the literature. Neurology 1994;44(11) 2111-2114. (Pubitemid 24349514)
41. Brighina F, Palermo A, Cosentino G, Fierro B. Prophylaxis of hemicrania continua two new cases effectively treated with topiramate. Headache 2007;47(3) 441-443. (Pubitemid 46426421)
42. Camarda C, Camarda R, Monastero R. Chronic paroxysmal hemicrania and hemicrania continua responding to topiramate two case reports. Clin Neurol Neurosurg 2008;110(1) 88-91. (Pubitemid 350266177)
43. Burns B, Watkins L, Goadsby PJ. Treatment of hemicrania continua by occipital nerve stimulation with a novel bion device long-term follow-up of a crossover study. Lancet Neurol 2008;7(11) 1001-1012.
44. Nagy AJ, Gandhi S, Bhola R, Goadsby PJ. Intravenous dihydroergotamine for inpatient management of refractory primary headaches. Neurology 2011;77(20) 1827-1832.
45. Goadsby PJ. Is medication-overuse headache a distinct biological entity? Nat Clin Pract Neurol 2006;2(8) 401. (Pubitemid 44137934)